Clinical trial
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression…
NCT00481195 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00481195 |
|---|---|
| Title | Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder |
| Official title | An 8 Week Double Blind, Placebo-Controlled, Parallel Group, Fixed Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar I Depression |
| Intervention type | Drug |
| Interventions | Armodafinil, Placebo |
| Enrollment | 257 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 1, 2007 |
| Last update posted | Jul 19, 2013 |
| Countries | Bulgaria, Hungary, Romania, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: